Position in AZN
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$95,947
-$3,846 QoQ
Shares Held
506
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#1,248
of 1,459 holders
Holding Since
Sep 2022
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Strengthening Families & Communities, LLC holds $15,119,704 across 12 Drug Manufacturers - General names. AZN ranks #4 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
21,481 | $5,455,529 | |
| 2 | MRK |
Merck & Co., Inc.
|
41,350 | $5,313,475 | |
| 3 | LLY |
ELI LILLY & Co
|
3,421 | $4,103,250 | |
| 4 | AZN |
Astrazeneca PLC
This page
|
506 | $95,947 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
427 | $53,947 | |
| 6 | ABBV |
AbbVie Inc.
|
176 | $44,288 | |
| 7 | AMGN |
Amgen Inc
|
75 | $27,159 | |
| 8 | NVS |
Novartis AG
|
100 | $15,672 |
All Filings in AZN
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $95,947 | 506 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $99,793 | 506 | Shares | Sole | 2026-05-11 | |
| 2023-06-30 | $26 | 178 | Shares | Sole | 2023-07-26 | |
| 2023-03-31 | $25 | 178 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $24 | 178 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $9,761 | 178 | Shares | Sole | 2022-11-03 | |
| No filing history on record for this holder in this stock. | ||||||